Not Every PPI Is Free from Adverse Drug Reactions

Rabeprazole is often considered a safe and commonly prescribed proton pump inhibitor. However, even routinely used medications can cause rare hypersensitivity reactions.

Reported symptoms may include itching (pruritus), flushing, erythematous red spots, warmth, and, in severe cases, breathlessness, requiring immediate medical attention.

I have seen this type of reaction during my clinical posting after taking the thorough history we came to know that those reactions are due to rabeprazole. So I have gone a deep search about the adverse effects caused by PPI’s https://www.njppp.com/fulltext/28-1630774045.pdf?1784612067

According to the study’s findings and observations, prolonged PPI use may result in a number of adverse drug reactions (ADRs) that necessitate stopping the medication. PPI self-medication is frighteningly on the rise due to their easy availability without a prescription. One PPI is always recommended for each antibiotic; this leads to the irrational use of PPIs, which is concerning and has to be addressed. Preventing long-term self-medication and cutting back on the unnecessary prescription of PPIs should lessen these negative outcomes.
Physicians ought to be made aware of the ADRs. The long-term negative consequences of PPIs should be explained to the patient.

Never dismiss new symptoms simply because a medication is commonly prescribed. Early recognition of adverse drug reactions and reporting can improve patient safety.

Have you ever identified an unexpected ADR from a commonly used medication during your clinical postings?

MBH/PS

Great write-up! During my clinical rotations, I’ve seen similar overlooked ADRs—it’s so easy for unique drug side effects to be misattributed to a new viral illness or a different underlying condition. Your point about never dismissing new symptoms just because a drug is common is an excellent takeaway for both student clinicians and seasoned practitioners alike.

1 Like

That’s a valuable reminder @Saniya21 that “commonly prescribed” doesn’t always mean “risk-free.” During clinical training, even seemingly mild symptoms can be the first clue to an adverse drug reaction. Careful history-taking, clinical judgment and timely pharmacovigilance reporting are essential to improving patient safety.

1 Like